Effects of denosumab on peripheral lymphocyte subpopulations.
Rheumatology Unit, Department of Medicine, University of Verona, Policlinico Borgo Roma, Piazzale Scuro, 10, 37134, Verona, Italy. maurizio.rossini@univr.it.
Maurizio
M
Rossini
Rheumatology Unit, Department of Medicine, University of Verona, Policlinico Borgo Roma, Piazzale Scuro, 10, 37134, Verona, Italy.
Ombretta
O
Viapiana
Rheumatology Unit, Department of Medicine, University of Verona, Policlinico Borgo Roma, Piazzale Scuro, 10, 37134, Verona, Italy.
Silvano
S
Adami
Rheumatology Unit, Department of Medicine, University of Verona, Policlinico Borgo Roma, Piazzale Scuro, 10, 37134, Verona, Italy.
Luca
L
Idolazzi
Rheumatology Unit, Department of Medicine, University of Verona, Policlinico Borgo Roma, Piazzale Scuro, 10, 37134, Verona, Italy.
Francesco
F
Ghellere
Rheumatology Unit, Department of Medicine, University of Verona, Policlinico Borgo Roma, Piazzale Scuro, 10, 37134, Verona, Italy.
Gaia
G
Tripi
Immunology Unit, Department of Pathology, University Hospital, Verona, Italy.
Riccardo
R
Ortolani
Hematology Section, Department of Medicine, University of Verona, Verona, Italy.
Roberta
R
Zanotti
Rheumatology Unit, Department of Medicine, University of Verona, Policlinico Borgo Roma, Piazzale Scuro, 10, 37134, Verona, Italy.
Davide
D
Gatti
D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000069448:Denosumab / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016131:Lymphocyte Subsets / Q000187:drug effects*; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D000069448:Denosumab